The finely orchestrated cell death process of apoptosis is fundamental to vertebrate and invertebrate health and growth, while its dysregulation contributes to infectious disease pathology and malignancy. Additionally, it is vital to evaluate the effects on apoptosis of drug candidates for cancer therapy. In view of the important role apoptosis plays in health, disease, drug design, therapy and its conservation across species, it is therefore highly beneficial to be able to measure apoptosis. In this article we describe ApoqPCR, a protocol to measure apoptosis by absolute quantitation of an apoptotic hallmark: internucleosomally fragmented ('apoptotic') genomic DNA. Completely apoptotic DNA is generated, diluted to cover a 1000-fold biologically relevant range of concentrations, amplified by ligation-mediated qPCR and threshold cycles measured. This forms an apoptotic DNA standard curve. A cell number standard curve is also constructed.
Introduction
Apoptosis, a major form of programmed cell death, is understood as a means of removing damaged, aging or unwanted cells and is essential to embryogenesis, post-natal tissue maintenance, normal aging and immune system function. Vertebrate and invertebrate cells undergo apoptosis while plants also have a form of programmed cell death with functional and molecular similarities to animal apoptosis (1) . The regulation of apoptosis is critical to the health of the organism, and consequently its dysregulation in humans is associated both mechanistically and as a marker with several pathologies including viral infections, bacterial infections, myocardial ischaemia, stroke and malignancy. In addition, apoptosis can be intentionally potentiated by anti-cancer drugs, or unintentionally elevated by some antiretroviral therapies, making apoptosis a central concern in drug design and drug therapy. In view of the key role apoptosis plays in health, disease, drug design and therapy it is vital to be able to detect, and preferably measure, apoptosis. The protocol described in this article, ApoqPCR, advances the measurement of apoptosis by providing a high degree of robustness, sensitivity and specificity with advantages over current methods.
The molecular stages in mammalian apoptosis are now well characterized. A terminal stage in the process and indeed an apoptotic 'hallmark' -fragmentation of the nuclear genome -occurs when activated caspase-3 cleaves an endogenous endonuclease (DNA fragmentation factor, DFF, in humans (2)) to its active form. This nuclease specifically cleaves nuclear DNA along internucleosomal regions generating double-stranded and predominantly blunt-ended nucleic acid in multiples of approximately 180 to 200 bp lengths. However, though this characteristic 'ladder' of electrophoresed oligonucleosomal fragments can sometimes be detected when apoptosis is induced in vitro in cell culture systems, there is rarely enough for detection when organismal samples are studied. This is because degrees of basal apoptosis and even of dysregulated apoptosis in tissue pathology often account for only a small proportion of total genomic DNA.
Small in vivo changes in apoptosis levels are nevertheless relevant since subtle shifts in the correct equilibrium between apoptotic and non-apoptotic cells influence pathology (3) . With the generally low in vivo levels of apoptotic DNA in cell populations and without reliable detection, apoptotic DNA's utility as a marker for detecting or measuring apoptosis is limited.
In 1997 Staley and her team (4) reported a breakthrough method for amplifying apoptotic DNA, showing that it was indeed readily detectable in a comprehensive range of vertebrate and invertebrate tissues. The method developed a specific form of ligation-mediated PCR ("LM-PCR", Mueller et al (5) ; adapted by other investigators (6,7)) and exploited the predominance of blunt-ended, 5'-phosphorylated apoptotic DNA. With this method Staley et al were able to make qualitative comments about apoptosis in many different tissues, yet sensitive quantitation was lacking.
Our early attempts to convert LM-PCR into a quantitative tool involved post-electrophoretic trace quantitation of a 600 bp amplified apoptotic DNA population that was representative of the multipopulation pool of apoptotic DNA (8) . Though this approach yielded insights on the association of apoptosis with antiretroviral toxicities, it had a restricted dynamic range, limited control of inter-run variation, and slow turn-around time. In a subsequent article (the primary article for this protocol)
we integrated a modified LM-PCR with qPCR to create ApoqPCR. This overcomes the earlier problems and adds significant advances to measuring apoptosis generally (9) . Here, threshold cycles from apoptotic amplicons vary in semi-logarithmic relationship with the amount of apoptotic DNA. Though a multi-product PCR, correlation is reliable and well within qPCR tolerances. When combined with qPCR-based determination of cell number in the sample, an absolute figure, picogram apoptotic DNA per 1000 cells, is obtained. The workflow and molecular process for this protocol is shown in Figure 1 and Figure 2 .
We have compared ApoqPCR against other accepted apoptosis quantifiers (9), namely TUNELpositivity by flow cytometry, active caspase-3 measurement by ELISA, and Annexin-V measurement by flow cytometry, and found ApoqPCR to be more sensitive at resolving differences in low level apoptosis, while the broad and linear 1000-fold dynamic range of ApoqPCR allowed clearer resolution of apoptosis at higher levels. Moreover, the ability to reliably measure apoptosis from sub-100 cell equivalent amounts of genomic DNA gave ApoqPCR advantages in efficiency over TUNEL-positivity by fluorescence microscopy, and advantages in sample economy where other methods require many more cells at the point of measurement.
From a broader perspective, when comparing ApoqPCR against other apoptosis detectors / quantifiers (for Reviews see (10) (11) (12) (13) (14) (15) ), methods can be characterised by (a) the marker they detect or measure; (b) whether or not live cells are required at the time of measurement; (c) assessment in living or fixed cells; (d) single cell or cell population measurements; (e) simultaneous measurement from homogenous or heterogeneous cell populations; (f) detection, semiquantitative or absolute measurement of apoptosis; and (g) throughput capability. Referenced against these categories, ApoqPCR can provide highly sensitive and specific absolute measurement of a hallmark of apoptosis, over a wide and linear 1000-fold dynamic range, without the need for live cells at the point of measurement, from cell populations, with high through-put capability and capacity for robotisation. It is not designed however for fixed cells, single cell or live cell analysis, and unlike flow cytometry it cannot simultaneously distinguish pooled heterogeneous cell populations. Yet unlike flow cytometry it is not limited to (in many cases) a minimum of 10 4 cells or more.
Regarding the application and utility of ApoqPCR some comments are noteworthy. As long as the genomic DNA starting material from test samples has been purified and stored correctly and consistently, ApoqPCR will in principle be applicable to many vertebrate and invertebrate primary cell types and adherent or non-adherent cell lines. The long-term storage characteristics of correctly purified genomic DNA (years) and its re-usability means that longitudinal studies from archived samples are possible. ApoqPCR would not be applicable to forensic samples, however, because the method relies on undegraded apoptotic DNA. ApoqPCR has utility when (but not only when) sample recovery is restricted to minute amounts (for eg. the extraction of low cell numbers from punch needle biopsies) or if samples are precious and require conservation, because measurement is reliable from sub-100 cell-equivalent amounts (9) . The ability of ApoqPCR to measure apoptosis from small cell populations makes it a more rapid and arguably less labor-intensive alternative to visualisation of apoptosis by microscopy (9) . Since plant cells also undergo programmed cell death (16) with internucleosomal fragmentation (1, 17) , ApoqPCR may be a feasable measuring tool for plant cell death though in this case completely apoptotic DNA should be prepared from a representative plant cell type, and the cell number standard curve should be generated from amplicons targeting plant genomic DNA sequences. Moreover, a prerequisite for the utility of ApoqPCR (in its current form) in plant studies is production of bluntended internucleosomal fragments; to our knowledge the extent of this in plant apoptosis is not Triton X-100: (Ambion; cat. no. 0694-1L). 
Equipment
Gilson Pipetman P1000, P200, P20, P10, and P2 adjustable pipettes, or equivalent.
Spectrophotometer: NanoDrop ND-1000 (Thermo Scientific, Wilmington, DE, USA) or equivalent.
Gel Imaging and trace quantification: Bio-Rad (Bio-Rad, Hercules, CA, USA; email: LSG.TechServ.US@Bio-Rad.com) Gel-Doc XR Molecular Imager and Quantity One software version 4.6.0, or equivalent.
Flow cytometer: BD FACScan (BD Biosciences) or equivalent.
Haemocytometer or electronic cell counter.
Bench top centrifuge for eppendorf tubes.
Bench top centrifuge with adjustable brake for 50ml Falcon tubes: Eppendorf 5810 or equivalent. Microtitre plates for qPCR reactions: Framestar 96 by 4titude or equivalent. cat. no. 4ti-0900/C.
Microtitre plate caps for qPCR reactions: 4titude; cat. no. 4ti-0751 or equivalent.
Nutator Mixer: TCS Scientific Corporation or equivalent.
Biohazard containment hood for genomic DNA purification from cells and tissues and for cell culture.
PCR containment hood for preparation of PCR reactions.
Non-cyclic defrost -20°C and -80°C freezers.
Procedure 1 | Purify test sample genomic DNA
Critical Some cell types and tissues, for example adipose tissue, may require specialised protocols for gDNA purification that are not outlined here. We recommend that a standard purification procedure be applied to all samples to be tested after any specialised purification protocols have been completed, to minimise irregularities between samples. This standard purification procedure can be column-based, should remove protein and RNA and purify DNA within the range 150 bp to 30,000 bp. Quantitative recovery is not necessary. Pause point These suspensions can be quick frozen at -80°C to store indefinitely if needed.
Otherwise proceed immediately to gDNA purification. Pause point Either store at -80°C and thaw once before proceeding, or proceed to serial dilution (see below).
3 | Verify conversion of genomic DNA to completely apoptotic DNA 3.1) Electrophorese 0.5 or 1 µg fractions of completely apoptotic DNA on a 1.5% agarose 1x
Tris-Acetate-EDTA (TAE) gel. Stain for 50 min with ethidium bromide at 15 µg/ml then destain for 30 min in double-distilled water, or alternatively incorporate SYBR Safe at 1x in the gel.
Critical The quality of information obtained from trace intensity profiles depends on agarose gel quality. Pour gels that are free from particulate matter and load samples precisely into wells to acquire a dependable electrophoretic image. Sort at least 10,000 events at each measurement. ng/µl (40%) to 9.03 pg/µl covering a 1000-fold range (6 serial dilutions). '40%' apoptotic DNA is chosen as a starting dilution because, from experience, samples generated in vitro and especially clinical samples rarely exceed this upper level. See Table 1 for a suggested dilution scheme. Table 2 .
Critical Calibrated pipettes that accurately deliver sub-20 µl and sub-2 µl volumes are essential.
Perform all liquid handling under PCR conditions. Due to the presence of polyethylene glycol, reactions must be mixed thoroughly to homogeneity.
Critical Linker synthesis by different manufacturers can dramatically influence the threshold cycle and replicate reproducibility by changing background fluorescence during qPCR. This may be due to extraneous solute material carried over during synthesis. The manufacturer used here is given in Reagents and Equipment.
6.1.3) Carefully place tubes containing assembled reaction components in a PCR thermal cycler
avoiding any droplets on tube sides.
6.1.4) Anneal linkers under the following programmed conditions (or similar):
55°C for 10 min, 50°C to 15°C in 5°C/8 min increments, 10°C for 20 min (see 6.1.5 below), 16°C for 16 hr, 2°C to 4°C on hold.
Critical Machine-control the temperature gradient for annealing runs to avoid inter-run variability.
A 'Pause' function in the cycler software is necessary.
6.1.5) For ligation of annealed linkers to apoptotic target DNA, halfway through the 10°C step (ie.
at the 10 min point), pause the program and to each PCR tube, add 2.4 U of 1 U /µl T4 DNA ligase, mix, close the tube, then when the series of tubes is completed un-pause the program to complete the 10°C incubation for the remaining 10 min, ramp to 16°C for 16 hr for ligation (overnight), then 2 to 4°C on hold.
Critical The addition of T4 DNA ligase occurs to reaction tubes while they reside in the thermal cycler heating block. Open each tube in turn and manually add ligase. Mixing is critical especially considering the presence of viscous polyethylene glycol. Add, expel and mix ligase with the pipette tip, adopting the same manual procedure for each tube to aid reproducibility. We have found that 'extended length' filter tips on a Gilson P10 hinder complete expulsion, while standard length P10 tips assist expulsion.
6.1.6) After the 16 hr ligation, dilute all 24 µl annealed/ligated reactions (now 26.4 µl due to ligase addition) to 80 µl with 53.6 µl TE. Mix thoroughly. Note that 7.50 µl from these reactions will be used 3 times for 3 replicates in the qLM-PCR reactions.
Pause point The completed and diluted annealed/ligated reactions for test samples are normally used for one set of triplicate qLM-PCR runs. However, they can be frozen/thawed once at -20°C or -80°C for a repeat run on another day without significant change to threshold cycles.
6.2) Prepare and perform qLM-PCR. Table 3 and To do this, first add 17.5 µl of the master mix into each well of the qPCR plate without employing the pipette's second stage expulsion step (this eliminates unwanted bubbles while still being reproducible, and is faster). Then add 7.5 µl of the appropriate diluted annealed/ligated reaction per well. When adding diluted annealed/ligated reactions to wells, for each well pipette up and down a consistent number of times, finishing with a second stage expulsion. Critical Proteinase K must be totally inactivated to avoid interference in downstream reactions.
6.2.1) Prepare qLM-PCR master mix as in
7.6) Create six 5-fold serial dilutions from 50,000 cell-equivalents per 1.62 µl to 16 cellequivalents per 1.62 µl using TE as diluent. A suggested dilution series is given in Table 7 , and mix by pipetting up and down 5 times, finishing with a second-stage expulsion.
Critical The volume of 1.62 µl test sample gDNA is critical because it means that the same amount of test sample gDNA is added to both qLM-PCR and Cell Number qPCR reactions. Use high quality, calibrated pipettes under PCR conditions. 8.1.4) Before qPCR cycling, spin the capped qPCR plate at about 200 g for 5 sec to ensure all reaction contents are at the base of the wells.
8.1.5) Perform Cell Number qPCR with cycling conditions as shown in Table 8 .
Timing
Without using specialized purification protocols, test sample gDNA purification of many samples takes about a day. Generating and verifying completely apoptotic DNA from log phase Jurkat cell cultures takes 2 to 3 days. This excludes the optional TUNEL/flow cytometry step. Generating a lysate from healthy donor blood for the Cell Number qPCR standard curve takes about a day. Having standard curves established, 100 samples can be tested in triplicate by one operator in 5 days. The protocol is amenable to robotisation which would increase through-put considerably.
Troubleshooting Anticipated Results
Test sample genomic DNA
The concentration of test sample gDNA may be 'x' ng/µl but preferably about 5 ng/µl. The approximate figure of 5 ng/µl is useful because it usually allows values to fall neatly within the standard curves. Using the same amount of test sample gDNA in both qLM-PCR and Cell
Number qPCR allows a final figure of pg apoptotic DNA per 1000 cells to be calculated.
Extent and quality of completely apoptotic DNA Trace quantification using a gel imager and suitable software provides a sensitive way to evaluate the extent of conversion of genomic DNA to apoptotic DNA. See Figure 3 . With completely apoptotic DNA prepared as in this protocol we observe by trace profiles that no genomic DNA remains unconverted to apoptotic DNA. DNA needs to be essentially completely apoptotic so that spectrophotometric quantitation is accurate. We find the generation of completely apoptotic DNA to be verifiable and reproducible. Over 3 independent preparations, percent conversion to apoptotic DNA has been 100% by trace quantification. Further verification by TUNEL/flow cytometry has found extent conversion for those separate preparations, expressed as percent TUNEL-positivity, to be 99.3, 98.9 and 98.8) (9) . See Figure 4 .
Economy of completely apoptotic DNA Ten ml Jurkat cells cultured with 8 µM staurosprine for 5 hr yields completely apoptotic DNA that is sufficient to run 300 standard curves, for a maximum of 7,500 test samples run in triplicate with those standard curves. Alternatively, since each diluted 80 µl annealed/ligated reaction (containing apoptotic standard DNA) can be used for 2 or even 3 triplicate sets on the same day (stored on the day on ice, not frozen), 600 or 900 standard curves are possible.
Contamination issues
During annealing/ligations tubes are opened for a short time in the thermal cycler heating block. However, this PCR does not involve oligomers targeting gDNA sequences; the linkers used here do not anneal to any specific gDNA sequence and instead ligate to the blunt ends of apoptotic fragments. Lack of contamination is therefore anticipated and this is consistent with our experience over hundreds of reference curve runs concurrent with negative controls. Nevertheless this step should be done in a dedicated and clean PCR suite.
qLM-PCR for the apoptotic standard curve
The qLM-PCR program takes approximately 185 min. A dissociation (melt) curve will not be useful as this is a multi-product PCR. Note that the qLM-PCR reaction conditions have been systematically optimised such that SYBR Green I fluorescence from primer-dimer formation and other non-specific amplification accounts for only about 3% of total fluorescence. Molecular probes are not compatible with the molecular events of this technology and, if they were compatible, would add considerably to the cost.
Apoptotic standard curve characteristics Apoptotic DNA standard curves are shown in Figure 5 . Reactions using Taq DNA polymerase from two different manufacturers give slightly different Ct's (n=10 runs and n=14 runs). Plotted is mean ± one standard deviation. Accept if the standard curve correlation is R 2 ≥ 0.985. Expect efficiency around 72%, due probably to the fact that Taq polymerase amplifies many sizeable products concurrently.
Similar success has been achieved with Taq DNA polymerase purified from Thermus aquaticus YT-1 from either Scientifix or Fisher Biotec. We have not had success with some higher fidelity or high processivity thermostable polymerases (KlenTaq™, Sigma; KODHotstart™, Novagen; Immolase™, Bioline) using these cycling conditions.
Over 24 independent runs we find the mean R 2 correlation to be 0.993 (0.986 to 0.999) and mean efficiency to be 71% (66 to 78%). Mean Cts and ranges for the 6 standards over 14 independent runs were 12. ). The equation generated from n=14 runs using Taq polymerase 'A' was y = -4.254log (x)+29.54, while from n=10 runs using Taq polymerase 'B' was y = -4.379log (x)+29.37 (9).
Cell Number qPCR
For Cell Number qPCR the reactions comprise a highly-optimised component set that effectively eliminates non-specific SYBR fluorescence. Dissociation (melt) curves confirm a single specific amplification product and therefore are not routinely performed.
Cell Number standard curve characteristics Representative Cell Number standard curves are combined in Figure 6 . Table 2 Reaction components and volumes for annealing / ligation reactions. Table 3 : Reaction components and volumes for qLM-PCR reactions.
Download Table 3 Reaction components and volumes for qLM-PCR reactions. Table 4 : Preparing a complex of Taq DNA polymerase and anti-Taq antibody.
Download Table 4 Preparing a complex of Taq DNA polymerase and anti-Taq antibody. Table 5 Cycling conditions for qLM-PCR. Table 6 : Construction of dilutions for the Cell Number standard curve.
Download Table 6 Construction of dilutions for the Cell Number standard curve. Table 7 Reaction components and volumes for Cell Number qPCR. Table 8 Cycling conditions for Cell Number qPCR. Table 9 : Troubleshooting ApoqPCR: Potential problems, reasons and possible solutions.
Download Table 9 Troubleshooting ApoqPCR: Potential problems, reasons and possible solutions.
Associated Publications
This protocol is related to the following articles:
A new way of measuring apoptosis by absolute quantitation of inter-nucleosomally fragmented genomic DNA
